HighTower Advisors
ELV icon

HighTower Advisors’s Elevance Health ELV Stock Holding History

HighTower Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4
Closed -$17K – 3320
2022
Q1 		$17K Buy
+4
New +$1.83K ﹤0.01% 3180

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

HighTower Advisors's ELV Position: Q1 2026 in Review

HighTower Advisors increased its Elevance Health (ELV) stake by 0.4% in Q1 2026, buying an estimated $45.4K and bringing the position to 34,603 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #880.

HighTower Advisors first reported a position in ELV in Q3 2013 and has held it in 49 quarters since. The position peaked at $49.2M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • HighTower Advisors held 34,603 shares of Elevance Health worth $10.1M as of Q1 2026.
  • HighTower Advisors bought 138 Elevance Health shares in Q1 2026, an estimated $45.4K.
  • Elevance Health made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #880 holding.
  • HighTower Advisors first reported a position in Elevance Health in Q3 2013 and has held it in 49 quarters since.
  • HighTower Advisors's Elevance Health position peaked at $49.2M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.